Tredaptive

Country: Նոր Զելանդիա

language: անգլերեն

source: Medsafe (Medicines Safety Authority)

active_ingredient:

Laropiprant 20mg;  ; Nicotinic acid 1000mg

MAH:

Merck Sharp & Dohme (New Zealand) Limited

INN:

Laropiprant 20 mg

pharmaceutical_form:

Tablet

composition:

Active: Laropiprant 20mg   Nicotinic acid 1000mg Excipient: Colloidal silicon dioxide Croscarmellose sodium Hyprolose Hypromellose Lactose monohydrate Magnesium stearate Microcrystalline cellulose Sodium stearyl fumarate

units_in_package:

Blister pack, Al/Al - 7 tablets, 7 tablets

class:

Prescription

prescription_type:

Prescription

manufactured_by:

F.I.S. Fabbrica Italiana Sintetici SpA

leaflet_short:

Package - Contents - Shelf Life: Blister pack, Al/Al - 7 tablets - 7 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 14 tablets - 14 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 28 tablets - 28 tablets - 24 months from date of manufacture stored at or below 30°C - Blister pack, Al/Al - 56 tablets - 56 tablets - 24 months from date of manufacture stored at or below 30°C

authorization_date:

2007-08-29